Company / Total Debt
Edwards Lifesciences Total Debt History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$598.3M
FY2025
5-year range
$595.7M / $598.3M
FY2021-FY2025
Trend
+0.1%
vs FY2024
Sector context
#62 of 100
Health Care
What the data says
At $598M, Edwards Lifesciences's total debt ranks #39 of 100 in the Health Care sector. Total Debt has increased for 8 consecutive years, from $438M in FY2017 to $598M in FY2025.
Based on SEC 10-K filings.
$598M in FY2025 with a 5-year CAGR of +0.1%.
Remained stable around $598M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- +0.1%
- 5-Year CAGR
- +0.1%
- 10-Year CAGR
- -
Sector benchmark
#39 of 100 in Health CareTop 38% of 100This company $598.3M Sector average $4.6B
▼
-86.9% below sector average
Key checks
Key Insights
- Edwards Lifesciences's total debt has grown for 8 consecutive years.
- 5-year CAGR of +0.1%, indicating consistent growth.
- In FY2025, total debt increased 0.1% year-over-year.
- Ranks #62 out of 100 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $598.3M | +0.1% |
| FY2024 | $597.7M | +0.1% |
| FY2023 | $597.0M | +0.1% |
| FY2022 | $596.3M | +0.1% |
| FY2021 | $595.7M | +0.1% |
| FY2020 | $595.0M | +0.1% |
| FY2019 | $594.4M | +0.1% |
| FY2018 | $593.8M | +35.4% |
| FY2017 | $438.4M | -46.7% |
| FY2016 | $822.3M | +37.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026